Contravisory Investment Management, Inc. Takeda Pharmaceutical CO LTD Transaction History

Contravisory Investment Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$15.03 - $16.32 $10,596 - $11,505	705 Added 6.84%	11,006 $170,000
Q2 2023 Jul 12, 2023	BUY	$15.57 - $17.11 $62,264 - $68,422	3,999 Added 63.46%	10,301 $161,000
Q1 2023 Apr 12, 2023	BUY	$15.28 - $16.48 $9,030 - $9,739	591 Added 10.35%	6,302 $103,000
Q4 2022 Jan 13, 2023	SELL	$12.42 - $15.62 $136 - $171	-11 Reduced 0.19%	5,711 $0
Q2 2022 Jul 13, 2022	BUY	$13.12 - $15.03 $75,072 - $86,001	5,722 New	5,722 $80,000
Q4 2020 Jan 13, 2021	SELL	$15.39 - $18.97 $22,438 - $27,658	-1,458 Closed	0 $0
Q2 2020 Jul 09, 2020	SELL	$14.59 - $19.5 $1,254 - $1,677	-86 Reduced 5.57%	1,458 $28,000
Q1 2020 Apr 09, 2020	BUY	$13.02 - $20.31 $1,002 - $1,563	77 Added 5.25%	1,544 $23,000
Q4 2019 Jan 09, 2020	SELL	$16.88 - $20.83 $286 - $354	-17 Reduced 1.15%	1,467 $29,000
Q3 2019 Oct 07, 2019	BUY	$16.15 - $17.99 $1,388 - $1,547	86 Added 6.15%	1,484 $26,000
Q1 2019 Apr 08, 2019	BUY	$16.7 - $21.52 $23,346 - $30,084	1,398 New	1,398 $28,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.